
news report
FDA Picks Dexcom for First TEMPO Digital Health Pilot
The glucose program will generate real-world evidence inside Medicare’s ACCESS model as FDA plans up to about 10 participants in each of four clinical-use areas.
topics

news report
The glucose program will generate real-world evidence inside Medicare’s ACCESS model as FDA plans up to about 10 participants in each of four clinical-use areas.

news report
A 1,173-person NIH trial found a 21% lower risk of developing two chronic conditions; metformin did not significantly reduce that outcome.